125 related articles for article (PubMed ID: 11522326)
1. Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses.
Zapata A; Witkin JM; Shippenberg TS
Neuropharmacology; 2001 Sep; 41(3):351-9. PubMed ID: 11522326
[TBL] [Abstract][Full Text] [Related]
2. Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels.
Zapata A; Shippenberg TS
Neuropharmacology; 2005 Jan; 48(1):43-50. PubMed ID: 15617726
[TBL] [Abstract][Full Text] [Related]
3. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice.
Koeltzow TE; Xu M; Cooper DC; Hu XT; Tonegawa S; Wolf ME; White FJ
J Neurosci; 1998 Mar; 18(6):2231-8. PubMed ID: 9482807
[TBL] [Abstract][Full Text] [Related]
4. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice.
Boulay D; Depoortere R; Rostene W; Perrault G; Sanger DJ
Neuropharmacology; 1999 Apr; 38(4):555-65. PubMed ID: 10221759
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists.
Boulay D; Depoortere R; Perrault G; Borrelli E; Sanger DJ
Neuropharmacology; 1999 Sep; 38(9):1389-96. PubMed ID: 10471093
[TBL] [Abstract][Full Text] [Related]
7. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
Garner KJ; Baker LE
Pharmacol Biochem Behav; 1999 Oct; 64(2):373-8. PubMed ID: 10515316
[TBL] [Abstract][Full Text] [Related]
8. Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.
L'hirondel M; Chéramy A; Godeheu G; Artaud F; Saiardi A; Borrelli E; Glowinski J
Brain Res; 1998 May; 792(2):253-62. PubMed ID: 9593923
[TBL] [Abstract][Full Text] [Related]
9. 7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment.
Pritchard LM; Logue AD; Hayes S; Welge JA; Xu M; Zhang J; Berger SP; Richtand NM
Neuropsychopharmacology; 2003 Jan; 28(1):100-7. PubMed ID: 12496945
[TBL] [Abstract][Full Text] [Related]
10. Cocaine sensitization prevents the hypolocomotor effects of high but not low doses of PD 128,907.
Prinssen EP; Koek W; Kleven MS
Eur J Pharmacol; 1998 Aug; 355(1):19-22. PubMed ID: 9754934
[TBL] [Abstract][Full Text] [Related]
11. Effects of the dopamine D3 antagonist PD 58491 and its interaction with the dopamine D3 agonist PD 128907 on brain dopamine synthesis in rat.
Whetzel SZ; Shih YH; Georgic LM; Akunne HC; Pugsley TA
J Neurochem; 1997 Dec; 69(6):2363-8. PubMed ID: 9375667
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907: role of presynaptic dopamine D2 autoreceptors.
Bristow LJ; Cook GP; Patel S; Curtis N; Mawer I; Kulagowski JJ
Neuropharmacology; 1998 Jun; 37(6):793-802. PubMed ID: 9707293
[TBL] [Abstract][Full Text] [Related]
13. Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
Richtand NM; Welge JA; Levant B; Logue AD; Hayes S; Pritchard LM; Geracioti TD; Coolen LM; Berger SP
Neuropsychopharmacology; 2003 Aug; 28(8):1422-32. PubMed ID: 12700693
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
[TBL] [Abstract][Full Text] [Related]
15. D(3) receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens.
Zapata A; Shippenberg TS
J Neurochem; 2002 Jun; 81(5):1035-42. PubMed ID: 12065616
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys.
Spealman RD
J Pharmacol Exp Ther; 1996 Sep; 278(3):1128-37. PubMed ID: 8819495
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.
Bowery BJ; Razzaque Z; Emms F; Patel S; Freedman S; Bristow L; Kulagowski J; Seabrook GR
Br J Pharmacol; 1996 Dec; 119(7):1491-7. PubMed ID: 8968560
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907.
Witkin J; Gasior M; Acri J; Beekman M; Thurkauf A; Yuan J; DeBoer P; Wikström H; Dijkstra D
Eur J Pharmacol; 1998 Apr; 347(2-3):R1-3. PubMed ID: 9741997
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists.
Xu M; Koeltzow TE; Cooper DC; Tonegawa S; White FJ
Synapse; 1999 Mar; 31(3):210-5. PubMed ID: 10029239
[TBL] [Abstract][Full Text] [Related]
20. Reduced basal and ethanol stimulation of striatal extracellular dopamine concentrations in dopamine D2 receptor knockout mice.
Job MO; Ramachandra V; Anders S; Low MJ; Gonzales RA
Synapse; 2006 Aug; 60(2):158-64. PubMed ID: 16715495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
